Search

everythinglearnresearchcommunity

for

Search:↓

The FDA warned about safety issues with remdesivir and tofacitinib, finasteride is linked to suicidality, potent topical corticosteroids increase osteoporosis risk, henna can cause hemolysis in G6PD deficiency, chemotherapeutic agents can cause adverse reactions, drug interactions are common in cancer patients, ketamine can reduce at-risk drinking, high dose of anticholinergics increases dementia risk in Parkinson's patients, and prenatal exposure to second-generation antipsychotics increases pregnancy complications.

Cosmetovigilance and clinical pharmacists can enhance safety in cosmetic treatments, especially for those with diabetes.

Stem cells from hair follicles can safely treat hair loss.

Finasteride for hair loss may cause long-lasting side effects like impotence and low libido, but trials lack proper safety reporting.

Low dose cyclical nutrition therapy can consistently and safely improve hair growth and density without needing anti-androgens.

The laser system can safely improve recovery and quality of life for cervical cancer patients after surgery.

UC-MSCs derived secretome therapy may help treat hair loss safely.

The Blood Glucose Management Service improved patient safety and outcomes in managing blood sugar in hospitalized patients.

Trilostane effectively and safely treats dogs with pituitary-dependent hyperadrenocorticism, improving symptoms and adrenal gland size.

Minoxidil response testing helps treat hair loss effectively and safely.

Finasteride gel effectively and safely reduces hair thickness in women with excessive hair growth.

Essential oils can improve health but must be used safely under professional guidance.

Guidelines help safely perform cosmetic procedures on vitiligo patients to avoid new skin lesions.

Extracellular vesicles show promise for medical use but face challenges in standardization and safety.

Ritlecitinib is being tested for effectiveness and safety in treating severe alopecia areata.

2.2% minoxidil gel effectively and safely treats alopecia areata.

The serum improves facial skin quality safely and effectively.

Fluridil safely promotes hair growth in men with androgenetic alopecia.

PDRN helps repair tissue and improve wound healing with a high safety profile.

Topical flutamide works as well as hydroquinone for melasma but needs more safety checks.

Testosterone can help premenopausal and postmenopausal women with low sexual desire, but its long-term safety is unclear and it's not widely approved for this use.

ADSC-CM treatment improved hair density and thickness in women with hair loss, safely and effectively.

Testosterone therapy aims to treat hormone deficiencies and various conditions safely and effectively, but requires careful patient monitoring due to potential side effects.

JAK inhibitors effectively and safely treat alopecia areata with few serious side effects.

PRP is a promising alternative for alopecia areata due to its safety and patient satisfaction.

Low-dose dutasteride effectively and safely promotes hair growth in men with androgenetic alopecia.

SVF cell transplantation improves skin regeneration safely.

The guidelines advise against using testosterone and DHEA in women for most conditions due to safety and effectiveness concerns, but suggest considering testosterone for postmenopausal women with low sexual desire.

ADSC-CE treatment safely increases hair density and thickness in androgenetic alopecia patients.

Platelet-rich plasma therapy is widely used in medicine for its effectiveness and safety, but more research is needed to fully understand its potential.